Thank you for sharing your brave stories Chris and Brenda. ⁦⁦Canadian Cholangiocarcinoma Collaborative 🍁💚⁩ supports you and we urge the other provinces to join Quebec in giving patients access to pemigatinib. Please don’t deny these Canadian patients hope. #CCA #FGF2R calgary.ctvnews.ca/this-has-to-ch…

What a week! Thank you to so many for your congratulations and kind messages of support. I am honoured to take on this challenging role and privileged to work with amazing colleagues The Ottawa Hospital and uOttawa | Faculté de médecine, Faculty of Medicine!

Great #EarthDay webinar today on greening research labs! Thanks to our speakers Dr. Rebecca Auer Rebecca Auer, MD & Carole Dore of The Ottawa Hospital & thanks to all who attended! If you missed it - stay tuned - in the coming days we'll post the video online. #Summit4CISpeakerSeries

2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine ESMO Open doi.org/10.1016/j.esmo… 🔎systematic review & meta-analysis of 6 trials 👉ORR 10%, DCR 50%, mPFS 3mo, mOS 6,5 mo 🤨Hmm, we need to do better... ESMO - Eur. Oncology ILCA EASLnews #livertwitter

Biliary tract cancers: 🇫🇷 national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT) doi.org/10.1016/j.ejca… 👏comprehensive recommandations ESMO - Eur. Oncology ILCA EASL Education

Great to see Rebecca Auer, MD sharing progress & opportunities Canadian Cholangiocarcinoma Collaborative 🍁💚 #advocacy #curecc 💚 at GI working group CCTG #CCTG2024 🇨🇦

Pertuzumab + Trastuzumab in Biliary Tract Cancer With ERBB2/3 Alterations Journal of Clinical Oncology doi.org/10.1200/JCO.23… 🔎 TAPUR phs 2 👉DC: 40%; ORR: 32% 👉PFS: 11; mOS 30 weeks 🧐Activity in pts w/ ERBB2/3 amplification, overexpression or mutations ESMO - Eur. Oncology EASLnews ILCA Cholangiocarcinoma Foundation

🎙️First in studio experience today joining Matt Galloway to talk about team diversity in the operating room! with input from @SarooSharda_MD 📻🎧Tune in The Current on CBC Radio to listen Thanks for having me CBC!

On May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in Ottawa.

Ontario woman with incurable cancer pushing province to cover rare cancer drug | CTV News kitchener.ctvnews.ca/kitchener-ont-…

Without funding, Canadian patients have fallen behind the gold standard of care. Read about Noor's fight - an issue many Canadians with CCA are facing - and sign the petition in the tweet below to stand with her and her family 💚 #CCAHope kitchener.ctvnews.ca/kitchener-ont-…

📢 Today in Parliament: Urgent discussions on ensuring #Pemazyre coverage for patients with FGFR2 fusion-driven cholangiocarcinoma. Access to life-saving treatments shouldn't be a privilege—it's a right. Let's support equitable healthcare for all! #HealthForAll #CancerTreatment

Noor is one of MANY Canadians that are fighting for equitable access to life saving therapies. Spencer Turcotte updated us and CTV Kitchener news story about how Noor's case was brought to the House of Commons by Mike Morrice. WATCH THE STORY HERE: kitchener.ctvnews.ca/federal-appeal… Thank

On May 22 and 23, we gathered experts and people with cancer from across Canada for our Cancer Clinical Trials Forum. They met with politicians to talk about cancer treatment and innovation through clinical trials. Thanks to these committed Members of Parliament for leading this

We had our first meeting with Colorectal Cancer Resource & Action Network about aligning on our common goals! It's amazing to connect with GIANTS in the field of patient-focused cancer care and we are excited to attend their upcoming Biomarkers Conference on June 20-21st! Registration is FREE & open to all

Had a great meeting last night with 13 advocates discussing ways to mobilize and participate in advocacy for cholangiocarcinoma! These meetings are co-hosted with Cholangio-Hepatocellularcarcinoma Canada + Cholangiocarcinoma Foundation and happen every 2nd Wednesday of the month. See you July 10!

💚💚💚ALBERTA AGREES TO COVER PEMAZYRE FOR CHOLANGIOCARCINOMA 🙌🤝💪 #CCAHope #cholangiocarcinoma #Alberta #CancerTreatment #HealthcareVictory #AdvocacyWorks calgary.ctvnews.ca/alberta-agrees…

“Once you choose hope, anything is possible.” Christopher Reeve. I have repeated that to myself a thousand times. As doctors we always want to improve the outcome, and although sometimes we can’t, we can always affect the journey. Hope is key to every patient journey 💚

From JAMA: Among patients undergoing liver resection for a cancer-related indication, tranexamic acid did not reduce bleeding or blood transfusion but increased perioperative complications. ja.ma/4dza3WA

Thank you so much TOH/OHRI and uOttawa for the nomination. This is such an honour! 💕